Compare TTHI to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 3.55 |
|---|---|
| Trade Time: | Dec 24 |
| Change: | |
| Prev Close: | 3.57 |
| Open: | 3.61 |
| Bid: | 2.59 x 1000 |
| Ask: | N/A |
| 1y Target Est: | 6.35 |
| Day's Range: | 3.50 - 3.71 |
|---|---|
| 52wk Range: | 3.50 - 9.00 |
| Volume: | 95,522 |
| Avg Vol (3m): | 85,653.8 |
| Market Cap: | 82.42M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.95 |
| Div & Yield: | N/A (N/A) |
| Tue, Dec 15 | GenCorp, Transition Therapeutics: Biggest Price Decliners (GY, TTHI)at The Wall Street Journal Online |
| Tue, Dec 15 | Forget the Higher Dosesat Motley Fool |
| Tue, Dec 15 | CardioNet, Cyclacel: Midday Volume Playsat TheStreet.com |
| Tue, Dec 15 | Elan, Partner to Stop Alzheimers Trial After Nine Deathsat Fox Business |
| Tue, Dec 15 | Transition Therapeutics downgraded by Roth CapitalBriefing.com |
| Tue, Dec 15 | Elan, Transition modify Alzheimer drug trialat MarketWatch |
| Tue, Dec 15 | Safety Dogs Elan Alzheimer's Drug; Seattle Genetics Finds New Partner: BioBuzzat TheStreet.com |
| Tue, Dec 15 | Elan and Transition Therapeutics Announce Modifications to ELND005 Phase II Clinical Trials in Alzheimer's DiseaseBusiness Wire |
| Wed, Nov 11 | New Star Analyst Rankings for Transition Therapeutics, Inc.StarMine |
| Tue, Nov 10 | Transition Therapeutics Announces First Quarter Fiscal 2010 Financial ResultsGlobeNewswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.